This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ouyang, P. Articles by Karas, R. H. Search for Related Content PubMed PubMed Citation Articles by Ouyang, P. Articles by Karas, R. H.

Hormone Replacement Therapy and the Cardiovascular System

Lessons Learned and Unanswered Questions

Pamela Ouyang, MB, BS, FACC^_*,_*, Erin D. Michos, MD^_* and Richard H. Karas, MD, PhD, FACC

^_* Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Molecular Cardiology Research Center and the Division of Cardiology, Tufts-New England Medical Center, Boston, Massachusetts

View larger version (63K): [in a new window]   Figure 1 Estrogen: beneficial and thrombogenic effects. CAM = cell adhesion molecule; Cox-2 = cyclooxygenase 2; ER = estrogen receptor; HRT = hormone replacement therapy; LDL = low-density lipoprotein; MCP = monocyte chemoattractant protein; MMP = matrix metalloproteinase; TNF = tumor necrosis factor; VSMC = vascular smooth muscle cell. Reprinted, with permission, from Mendelsohn and Karas (7).